RecruitingNCT05852522
Molecularly Aided Stratification for Tumor Eradication Research
NCT MASTER Plattform Molecularly Aided Stratification for Tumor Eradication Research
Sponsor
German Cancer Research Center
Enrollment
10,000 participants
Start Date
Nov 11, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
NCT/DKFZ/DKTK MASTER is a prospective, continuously recruiting, multicenter observational study for biology-guided stratification of adults with rare cancers, including rare subtypes of common entities, using comprehensive molecular profiling, and clinical decision-making in a multidisciplinary molecular tumor board.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Rare cancer (Incidence <6/100,000 persons/year) or Rare subtype of a more common entity (case-by-case decision; example: pancreatic ductal adenocarcinoma without KRAS mutation)
- Metastatic and/or locally advanced cancer with no curative therapy option and indication for systemic therapy
Exclusion Criteria1
- Severe neurological or psychiatric disorder interfering with the ability to give oral and written informed consent
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05852522